Literature DB >> 1511174

Sense and antisense TGF beta 3 mRNA levels correlate with cardiac valve induction.

J D Potts1, E B Vincent, R B Runyan, D L Weeks.   

Abstract

The formation of the valves in the heart is a spatially and temporally controlled process. A tissue interaction between the endothelium and its adjacent myocardium initiates the transformation of the endothelium into the mesenchymal precursors of the heart valve. One or more of the molecules implicated as critical for valve formation are members of the transforming growth factor beta family of molecules. Presented here is a spatial and temporal analysis of TGF beta 2 and TGF beta 3 in the chick heart during valve formation. We show that TGF beta 3 mRNA is concentrated in AV canal tissue where valve formation will occur, consistent with previous observations that TGF beta 3 production is critical during valve formation. Additionally, an RNA complementary to TGF beta 3 encoding mRNA is present in the heart. The temporally controlled appearance of RNA complementary to TGF beta 3 suggests that this molecule may play a role in the regulation of TGF beta 3 production in the heart.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511174     DOI: 10.1002/aja.1001930407

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  17 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 2.  Interplay of chromatin modifications and non-coding RNAs in the heart.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2013-10-10       Impact factor: 4.528

Review 3.  Noncoding RNA in development.

Authors:  Paulo P Amaral; John S Mattick
Journal:  Mamm Genome       Date:  2008-10-07       Impact factor: 2.957

Review 4.  Practical aspects of radio-isotopic in situ hybridization on RNA.

Authors:  A F Moorman; P A De Boer; J L Vermeulen; W H Lamers
Journal:  Histochem J       Date:  1993-04

5.  A novel transforming growth factor beta2 antisense transcript in mammalian lung.

Authors:  R K Coker; G J Laurent; K Dabbagh; J Dawson; R J McAnulty
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

6.  Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium.

Authors:  Harold E Olivey; Nathan A Mundell; Anita F Austin; Joey V Barnett
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

7.  Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.

Authors:  R K Coker; G J Laurent; S Shahzeidi; P A Lympany; R M du Bois; P K Jeffery; R J McAnulty
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

8.  Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1.

Authors:  Leslie A Frieden; Todd A Townsend; David B Vaught; Daniel M Delaughter; Yoonha Hwang; Joey V Barnett; Jin Chen
Journal:  Dev Dyn       Date:  2010-10-19       Impact factor: 3.780

9.  Chromatin-remodeling factors mediate the balance of sense-antisense transcription at the FGF2 locus.

Authors:  Lori A McEachern; Paul R Murphy
Journal:  Mol Endocrinol       Date:  2014-02-19

10.  Mathematical modeling of flow-generated forces in an in vitro system of cardiac valve development.

Authors:  Stefanie V Biechler; Jay D Potts; Michael J Yost; Lorain Junor; Richard L Goodwin; John W Weidner
Journal:  Ann Biomed Eng       Date:  2009-10-28       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.